Go back

Go to
Vincent Guillaumot

“We established EURÊKA at the same time as ARCHIMED, driven by our core mission of investing in healthcare industries to improve the well-being of patients in need. EURÊKA not only benefits from ARCHIMED’s financial support but, most importantly, it draws upon the dedicated time and energy of our team. Even as our team continues to grow rapidly, philanthropy remains an integral aspect of our identity.”

Vincent
Guillaumot

Managing Partner

Sector: Healthcare IT

LinkedIn

Vincent Guillaumot is a Managing Partner at ARCHIMED and President of the EURÊKA Foundation, ARCHIMED’s charitable foundation. He is a Board Member of Clubhouse International. Vincent has a long-standing relationship with other ARCHIMED Partners, since 2005.

Vincent holds close to 20 years of experience in the healthcare and private equity sectors. He began his career at Bain & Company as a consultant before joining 3i’s healthcare team. Prior to joining ARCHIMED, Vincent was the Managing Director of JS Bio (now Cerba HealthCare), a European medical diagnostics lab network.

Vincent currently holds board positions with Germany-based manufacturer of Immunohistochemistry (IHC) and In-Situ Hybridization (ISH), ZytoGroup, Italy-based producer of In Visto Diagnostics systems, DIESSE, US-based software company, Title21, Italy based manufacturer of aesthetic medicine, GPQ (WiQo), and US-based medical device solutions provider, Natus.

PORTFOLIO COMPANIES

Ad-Tech Medical Instrument
Zyto Group
DIESSE
PlasmidFactory
Title21 Health Solutions
Instem
WiQo
Natus Medical Incorporated